Eva M.d. Selhub - 15 Jul 2026 Form 4 Insider Report for MARIMED INC. (MRMD)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Jul 2026, 16:12:05 UTC
Prior SEC filing
12 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Eva Selhub

Key filing fact

Eva M.d. Selhub filed Form 4 for MARIMED INC. (MRMD) on 17 Jul 2026.

Key facts

  • This page summarizes Eva M.d. Selhub's Form 4 filing for MARIMED INC. (MRMD).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 17 Jul 2026, 16:12.

Change

  • Previous filing in this sequence was filed on 12 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001789639 Primary reporting owner

Selhub Eva M.D.

Relationship
Director
Address
C/O MARIMED INC., 10 OCEANA WAY, NORWOOD
Signature
/s/ Eva Selhub
Signature date
16 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MRMD transaction

Common stock

Options Exercise

Transaction value
Shares
+173,077
Change %
+31%
Price
$0.000000*
Shares after
730,748
Date
15 Jul 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MRMD transaction Derivative

Restricted Stock Units (RSU)

Award

Transaction value
Shares
+173,077
Change %
Price
$0.000000*
Shares after
173,077
Date
15 Jul 2026
Ownership
Direct
Underlying class
Common Stock, par value $.001 per share
Underlying amount
173,077
Exercise price
Footnotes
F1, F2
MRMD transaction Derivative

Restricted Stock Units (RSU)

Options Exercise

Transaction value
Shares
-173,077
Change %
-100%
Price
$0.000000*
Shares after
0
Date
15 Jul 2026
Ownership
Direct
Underlying class
Common Stock, par value $.001 per share
Underlying amount
173,077
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

RSUs convert to shares of common stock on a one-for-one basis.

Footnote F2

The RSUs were granted on July 15, 2026 and vested upon grant in accordance with the terms of the award agreement between the Issuer and the Reporting Person. Accordingly, no RSUs remain outstanding under this award.

SEC remarks

The RSUs were granted in lieu of cash as payment for a portion of the Reporting Person's fees for serving on the Issuer's Board of Directors.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .